
RaQualia Pharma Hits Day Low of JPY 556 Amid Price Pressure
2025-10-09 21:17:53RaQualia Pharma, Inc. faced a notable stock decline today, reaching an intraday low amid ongoing operational challenges. Despite a strong year-to-date performance, the company struggles with negative operating profit, low return on equity, rising raw material costs, and declining net sales, impacting its long-term outlook.
Read MoreNo announcement available
Corporate Actions
No corporate action available






